The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation the biorepository of the National Disease Research Interchange (NDRI) in Philadelphia, PA based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. NDRI is one of more than 8,000 CAP-accredited biorepository facilities worldwide.
“NDRI is proud to have earned CAP Accreditation,” said Bill Leinweber, president and CEO of NDRI. “This accreditation is testament to the dedication and shared commitment of all of our staff to assuring that the gifts with which we are entrusted to advance biomedical research are managed with the highest scientific standards.”
The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program.
During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
NDRI was first accredited by CAP in 2016. Accreditations occur every three years.